Nicholas B. D’Alessandro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicholas B. D’Alessandro has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- David A. Johnsonv
Division of Gastroenterology, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23501, USA
3 shared publications - Edward C. Oldfield
Sentara Gastroenterology Specialists, Norfolk, VA 23507, USA
2 shared publications - Priyata Dutta
Department of Internal Medicine, Presbyterian Hospital, Albuquerque, NM 87122, USA
2 shared publications - Tarun Vippa
Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC 20007, USA
2 shared publications - William K. Slover
Department of Internal Medicine, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23501, USA
2 shared publications Edward C. Oldfield Iv
Gastroenterology Division, Department of Internal Medicine, Macon and Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA 23507, USA; Sentara Gastroenterology Specialists, Norfolk, VA 23510, USA
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by MDPI AG in Microplastics
- Vol. 5 (4) , 229
Micro- and Nanoplastics and Liver Disease: Mechanistic Insights, Experimental Evidence, and Pathways to Hepatic Inflammation, Fibrosis, and Carcinogenesis
Micro–nanoplastics (MNPs) have emerged as a critical environmental pollutant with significant potential implications for the development of liver disease. These MNPs can accumulate in the liver, initiating a series of detrimental biological responses. One of the main mechanisms is the initiation of oxidative stress, which is marked by overproduction of reactive oxygen species harming cellular structures. This oxidative damage is closely linked to hepatic inflammation, where immune responses are triggered, exacerbating tissue injury and disrupting normal liver function. As a result, hepatic metabolism, detoxification, and immune regulation become compromised due to persistent MNPs exposure. Although in vitro and vivo models effectively show direct cellular toxicity, oxidative stress, and metabolic disruption, direct evidence from human studies is mostly confined to tissue detection and cross-sectional correlations. As a result, advanced pathological outcomes like the progression of hepatic fibrosis and the development of cancer are considered mechanistic hypotheses grounded in biological plausibility rather than confirmed human causation.
- 12 November 2026
- Published by MDPI AG in Microplastics
- Vol. 5 (4) , 229
Open AccessMicro- and Nanoplastics and Liver Disease: Mechanistic Insights, Experimental Evidence, and Pathways to Hepatic Inflammation, Fibrosis, and Carcinogenesis
Micro–nanoplastics (MNPs) have emerged as a critical environmental pollutant with significant potential implications for the development of liver disease. These MNPs can accumulate in the liver, initiating a series of detrimental biological responses. One of the main mechanisms is the initiation of oxidative stress, which is marked by overproduction of reactive oxygen species harming cellular structures. This oxidative damage is closely linked to hepatic inflammation, where immune responses are triggered, exacerbating tissue injury and disrupting normal liver function. As a result, hepatic metabolism, detoxification, and immune regulation become compromised due to persistent MNPs exposure. Although in vitro and vivo models effectively show direct cellular toxicity, oxidative stress, and metabolic disruption, direct evidence from human studies is mostly confined to tissue detection and cross-sectional correlations. As a result, advanced pathological outcomes like the progression of hepatic fibrosis and the development of cancer are considered mechanistic hypotheses grounded in biological plausibility rather than confirmed human causation.
- Open Access
- 3 October 2026
- Published by MDPI AG in Microplastics
- Vol. 5 (4) , 194
Potential Links Between Micro- and Nanoplastic Exposure, Enteric Neuropathy, and Gastrointestinal Dysmotility
Micro- and nanoplastics (MNPs) have emerged as ubiquitous environmental contaminants, with dietary ingestion serving as the primary route of human exposure. While their capacity to induce localized epithelial damage is well recognized, recent evidence suggests that MNPs can alter the complex regulatory networks governing gastrointestinal (GI) transit. The objective of this narrative review is to evaluate the role of MNP exposure as a possible pathogenic factor in GI dysmotility, assessing the intersection of neuromuscular toxicity, microbial dysbiosis, and barrier failure. A comprehensive literature search was conducted across major biomedical databases to synthesize emerging biomonitoring studies, preclinical models, and clinical correlations from the past five years characterizing MNP-mediated intestinal dysfunction. Ingestion of MNPs triggers a distinct, size-dependent, multifaceted, interconnected pathological triad characterized by ensuing oxidative stress, physical barrier dysfunction, and extensive microbiome reconfiguration. Rather than strict, isolated events, these insults interact in a self-perpetuating feedback loop. On a cellular level, nano-sized particles translocate across the intestinal lining via paracellular transport, persorption, or transcytosis, embedding into cell membranes and downregulating key tight junction (TJ) proteins (ZO-1, occludin, claudins). This mechanical and chemical disruption yields an overproduction of reactive oxygen species (ROS) and a concomitant reduction in anti-inflammatory, short-chain fatty acid (SCFA)-producing bacterial taxa (e.g., Bacteroidetes, Faecalibacterium, Roseburia). Crucially, this resulting mucosal disruption converges on the enteric nervous system (ENS). MNPs induce neuroendocrine derangements by perturbing cholinergic neurotransmission—characterized by acetylcholinesterase (AChE) inhibition, aberrant synaptic acetylcholine dynamics, and subsequent downregulation of muscarinic acetylcholine receptors (mAChRs)—ultimately resulting in uncoordinated smooth muscle contractility and delayed transit. In murine models, this enteric neuropathy manifests phenotypically as structural intestinal shortening, delayed gastric emptying, and chronic constipation. The intestinal defense network is susceptible to MNP bioaccumulation, wherein particle-induced barrier failure and microbial dysbiosis may contribute to downstream neuromuscular dysmotility. Understanding this interconnected oxidative-barrier–microbiome–neuromuscular axis is essential, positioning environmental plastic contamination as an emerging, potentially modifiable factor in the pathogenesis of functional bowel disorders.
- 3 October 2026
- Published by MDPI AG in Microplastics
- Vol. 5 (4) , 194
Open AccessPotential Links Between Micro- and Nanoplastic Exposure, Enteric Neuropathy, and Gastrointestinal Dysmotility
Micro- and nanoplastics (MNPs) have emerged as ubiquitous environmental contaminants, with dietary ingestion serving as the primary route of human exposure. While their capacity to induce localized epithelial damage is well recognized, recent evidence suggests that MNPs can alter the complex regulatory networks governing gastrointestinal (GI) transit. The objective of this narrative review is to evaluate the role of MNP exposure as a possible pathogenic factor in GI dysmotility, assessing the intersection of neuromuscular toxicity, microbial dysbiosis, and barrier failure. A comprehensive literature search was conducted across major biomedical databases to synthesize emerging biomonitoring studies, preclinical models, and clinical correlations from the past five years characterizing MNP-mediated intestinal dysfunction. Ingestion of MNPs triggers a distinct, size-dependent, multifaceted, interconnected pathological triad characterized by ensuing oxidative stress, physical barrier dysfunction, and extensive microbiome reconfiguration. Rather than strict, isolated events, these insults interact in a self-perpetuating feedback loop. On a cellular level, nano-sized particles translocate across the intestinal lining via paracellular transport, persorption, or transcytosis, embedding into cell membranes and downregulating key tight junction (TJ) proteins (ZO-1, occludin, claudins). This mechanical and chemical disruption yields an overproduction of reactive oxygen species (ROS) and a concomitant reduction in anti-inflammatory, short-chain fatty acid (SCFA)-producing bacterial taxa (e.g., Bacteroidetes, Faecalibacterium, Roseburia). Crucially, this resulting mucosal disruption converges on the enteric nervous system (ENS). MNPs induce neuroendocrine derangements by perturbing cholinergic neurotransmission—characterized by acetylcholinesterase (AChE) inhibition, aberrant synaptic acetylcholine dynamics, and subsequent downregulation of muscarinic acetylcholine receptors (mAChRs)—ultimately resulting in uncoordinated smooth muscle contractility and delayed transit. In murine models, this enteric neuropathy manifests phenotypically as structural intestinal shortening, delayed gastric emptying, and chronic constipation. The intestinal defense network is susceptible to MNP bioaccumulation, wherein particle-induced barrier failure and microbial dysbiosis may contribute to downstream neuromuscular dysmotility. Understanding this interconnected oxidative-barrier–microbiome–neuromuscular axis is essential, positioning environmental plastic contamination as an emerging, potentially modifiable factor in the pathogenesis of functional bowel disorders.
- Open Access
- 24 December 2025
- Published by Open Exploration Publishing in Exploration of digestive diseases
- Vol. 4, 1005107
Diverticulitis—new evidence to share with patients
Diverticulitis is one of the most common gastrointestinal causes of hospitalization in Western society. While previously characterized as a disease of older patients, new literature highlights an increasing incidence among the younger population. Over the past few decades, the understanding of etiology and management of diverticulitis has changed drastically. New data refute past beliefs while promoting other novel recommendations to mitigate incidence and subsequent complications. Data now confirms the safety and possible protective benefit of particulate food, while highlighting evidence-based approaches for the use of diagnostic imaging and antibiotics. We recognize modifiable and non-modifiable risk factors that are commonly seen throughout the literature and play a significant role in the management and prevention of diverticulitis. Emerging evidence also links chronic inflammation with subsequent microbial dysbiosis and alterations in the neuroendocrine system, leading to visceral hypersensitivity and perturbation of the gut-brain axis. This review provides a comprehensive update on acute uncomplicated diverticulitis according to the most recent evidence-based literature, encompassing the risks, diagnostic modalities, and management treatment regimens.
- 24 December 2025
- Published by Open Exploration Publishing in Exploration of digestive diseases
- Vol. 4, 1005107
Open AccessDiverticulitis—new evidence to share with patients
Diverticulitis is one of the most common gastrointestinal causes of hospitalization in Western society. While previously characterized as a disease of older patients, new literature highlights an increasing incidence among the younger population. Over the past few decades, the understanding of etiology and management of diverticulitis has changed drastically. New data refute past beliefs while promoting other novel recommendations to mitigate incidence and subsequent complications. Data now confirms the safety and possible protective benefit of particulate food, while highlighting evidence-based approaches for the use of diagnostic imaging and antibiotics. We recognize modifiable and non-modifiable risk factors that are commonly seen throughout the literature and play a significant role in the management and prevention of diverticulitis. Emerging evidence also links chronic inflammation with subsequent microbial dysbiosis and alterations in the neuroendocrine system, leading to visceral hypersensitivity and perturbation of the gut-brain axis. This review provides a comprehensive update on acute uncomplicated diverticulitis according to the most recent evidence-based literature, encompassing the risks, diagnostic modalities, and management treatment regimens.